2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
4
Seroma
3
Pancreatic Neoplasms
3
Rectal Diseases
1
Prostatic Neoplasms
1
Patient Satisfaction
1
Pancreatitis
1
Pancreatic Diseases
1
Pain, Postoperative
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms by Site
1
Lymphocele
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Interventions
Oxaliplatin
6
Irinotecan
5
Fluorouracil
5
Drug Therapy
4
Bevacizumab
4
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Capecitabine
3
5,10-methylenetetrahydrofolic acid
3
pembrolizumab
2
Ocoxin
2
Levoleucovorin
2
Folfox protocol
2
Exercise Test
2
Cyclophosphamide
2
Cetuximab
2
trifluridine tipiracil drug combination
1
sintilimab
1
repotrectinib
1
pralsetinib
1
penpulimab
1
napabucasin
1
lutetium Lu 177 dotatate
1
huachansu
1
guadecitabine
1
golotimod
1
encorafenib
1
copper dotatate CU-64
1
alectinib
1
XELOX
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Diseases
×
Drainage
×
Clear all
NCT01269567
2026-05-14
GRECCAR 5
University Hospital, Bordeaux
Phase 3
Completed
494 enrolled